Show simple item record

dc.contributor.authorPapaxoinis, Georgios
dc.contributor.authorWeaver, Jamie M
dc.contributor.authorKhoja, Leila
dc.contributor.authorPatrao, Ana
dc.contributor.authorStamatopoulou, Sofia
dc.contributor.authorAlchawaf, Alia
dc.contributor.authorOwen-Holt, Vikki
dc.contributor.authorGermetaki, Theodora
dc.contributor.authorKordatou, Zoe
dc.contributor.authorMansoor, Was
dc.date.accessioned2017-06-29T10:22:20Z
dc.date.available2017-06-29T10:22:20Z
dc.date.issued2017-05-19
dc.identifier.citationSignificance of baseline FDG-PET/CT scan as a method of staging regional lymph nodes in patients with operable distal oesophageal or gastroesophageal junction adenocarcinoma. 2017:1-9 Acta Oncolen
dc.identifier.issn1651-226X
dc.identifier.pmid28524708
dc.identifier.doi10.1080/0284186X.2017.1328127
dc.identifier.urihttp://hdl.handle.net/10541/620413
dc.description.abstractThe new American Joint Committee on Cancer eighth edition (AJCC8) staging is the first to describe separate clinical and pathology staging systems, but still has low performance to predict prognosis in patients with oesophageal/gastroesophageal junction (O/GOJ) adenocarcinoma, who are candidates for surgery. Recent studies have demonstrated that O/GOJ cancer patients with 18F-fluorodeoxyglucose (FDG) avid regional lymph nodes (RLNs) may have poor prognosis. The aim of our study was to examine whether the baseline assessment of the FDG uptake of RLN improves the prognostic accuracy of the new AJCC8 staging.
dc.language.isoenen
dc.rightsArchived with thanks to Acta oncologica (Stockholm, Sweden)en
dc.titleSignificance of baseline FDG-PET/CT scan as a method of staging regional lymph nodes in patients with operable distal oesophageal or gastroesophageal junction adenocarcinoma.en
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Oncology , The Christie NHS Foundation Trust , Manchester , UKen
dc.identifier.journalActa Oncologicaen
html.description.abstractThe new American Joint Committee on Cancer eighth edition (AJCC8) staging is the first to describe separate clinical and pathology staging systems, but still has low performance to predict prognosis in patients with oesophageal/gastroesophageal junction (O/GOJ) adenocarcinoma, who are candidates for surgery. Recent studies have demonstrated that O/GOJ cancer patients with 18F-fluorodeoxyglucose (FDG) avid regional lymph nodes (RLNs) may have poor prognosis. The aim of our study was to examine whether the baseline assessment of the FDG uptake of RLN improves the prognostic accuracy of the new AJCC8 staging.


This item appears in the following Collection(s)

Show simple item record